Valeant’s Insolvency Explained
Wednesday April 4th the Shock Exchange held a live stream event where he explained Valeant’s insolvency. The event was oversubscribed with thousands of investors and lawmakers tuning in. It was also very detailed and informative. The Shock Exchange walked investors through Valeant’s change in strategy from a pharma roll-up to becoming a traditional drug company and how that led to its insolvency. The video is available below:
Video: Valeant’s Insolvency Explained
Hey, Michael. Yeah, agreed, the EBITDA margins don”t excite me much; it”s the growth of asset values that I find offensive. I agree that the shock to the system is most likely to come on the revenue side, too. I just question the timing. We”ll see.